{"id":9867,"date":"2018-03-17T05:00:21","date_gmt":"2018-03-17T09:00:21","guid":{"rendered":"https:\/\/medicarereport.org\/?p=9867"},"modified":"2018-03-16T10:54:24","modified_gmt":"2018-03-16T14:54:24","slug":"genetic-tests-ordered-by-doctors-race-to-market-while-direct-to-consumer-tests-hinge-on-fda-approval","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=9867","title":{"rendered":"Genetic tests ordered by doctors race to market, while \u2018direct-to-consumer\u2019 tests hinge on FDA approval"},"content":{"rendered":"<p>(By Ike Swetlitz for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">WASHINGTON \u2014 The Food and Drug Administration is keeping tight watch on \u201cdirect-to-consumer\u201d genetic tests but has been taking a hands-off approach with similar tests that have a crucial distinction: a physician\u2019s sign-off. <a href=\"https:\/\/www.statnews.com\/2018\/03\/16\/genetic-tests-fda-regulation\/?_hsenc=p2ANqtz--Upz_rGFxPfot6kbGkiwSSZNxrr3e3H-fIni3dnEa9SzBXMsIc1sEPvSp6ZeFy_ONMI5nI6M-Pq4H5RbnY-qY-rFnUEA&amp;_hsmi=61416786\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Ike Swetlitz for STAT) WASHINGTON \u2014 The Food and Drug Administration is keeping tight watch on \u201cdirect-to-consumer\u201d genetic tests<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,31,14],"tags":[],"class_list":["post-9867","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-fda","category-medical-technology"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9867"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9867\/revisions"}],"predecessor-version":[{"id":9868,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9867\/revisions\/9868"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}